Senate Aide Advises FDA Dialogue, Not Legislation, To Obtain User Fee Relief

Manufacturers seeking to revise CDRH performance goals and user fee collection targets are unlikely to find a suitable vehicle in MDUFMA "trigger-fix" legislation this fall

More from Archive

More from Medtech Insight